Literature DB >> 24557593

Evolving role of PET/CT with different tracers in the evaluation of pulmonary neuroendocrine tumours.

Giorgio Treglia1, Luca Giovanella, Filippo Lococo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24557593     DOI: 10.1007/s00259-014-2695-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  14 in total

1.  Synchronous bilateral bronchial carcinoid diagnosed with combined dual tracer ((18)F-FDG and (68)Ga-DOTATOC) PET/CT scans.

Authors:  M Paci; F Lococo; C Rapicetta; M Roncali; A Cavazza; G Treglia; G Sgarbi
Journal:  Rev Esp Med Nucl Imagen Mol       Date:  2013-10-16       Impact factor: 1.359

2.  The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.

Authors:  Craig E Daniels; Val J Lowe; Marie-Christine Aubry; Mark S Allen; James R Jett
Journal:  Chest       Date:  2007-01       Impact factor: 9.410

Review 3.  PET/CT imaging in different types of lung cancer: an overview.

Authors:  Valentina Ambrosini; Silvia Nicolini; Paola Caroli; Cristina Nanni; Arianna Massaro; Maria Cristina Marzola; Domenico Rubello; Stefano Fanti
Journal:  Eur J Radiol       Date:  2011-03-31       Impact factor: 3.528

4.  Divergent management strategies for typical versus atypical carcinoid tumors of the thoracic cavity.

Authors:  Christian C Okoye; David M Jablons; Thierry M Jahan; Jasleen Kukreja; Shayne Cardozo; Sue S Yom
Journal:  Am J Clin Oncol       Date:  2014-08       Impact factor: 2.339

5.  Spectrum of pulmonary neuroendocrine proliferations and neoplasms.

Authors:  Ryo E C Benson; Melissa L Rosado-de-Christenson; Santiago Martínez-Jiménez; Jeffrey R Kunin; Paul P Pettavel
Journal:  Radiographics       Date:  2013-10       Impact factor: 5.333

6.  Grading the neuroendocrine tumors of the lung: an evidence-based proposal.

Authors:  G Rindi; C Klersy; F Inzani; G Fellegara; L Ampollini; A Ardizzoni; N Campanini; P Carbognani; T M De Pas; D Galetta; P L Granone; L Righi; M Rusca; L Spaggiari; M Tiseo; G Viale; M Volante; M Papotti; G Pelosi
Journal:  Endocr Relat Cancer       Date:  2013-12-16       Impact factor: 5.678

Review 7.  Is sublobar resection equivalent to lobectomy for surgical management of peripheral carcinoid?

Authors:  Jonathan Afoke; Carol Tan; Ian Hunt; Mustafa Zakkar
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-03-06

8.  A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.

Authors:  Irfan Kayani; Brendon G Conry; Ashley M Groves; Thida Win; John Dickson; Martyn Caplin; Jamshed B Bomanji
Journal:  J Nucl Med       Date:  2009-11-12       Impact factor: 10.057

Review 9.  Neuroendocrine tumors of the lung: hystological classification, diagnosis, traditional and new therapeutic approaches.

Authors:  A Cueto; F Burigana; A Nicolini; F Lugnani
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

10.  Evaluation of the role of [18F]FDG-PET/CT and [68Ga]DOTATOC-PET/CT in differentiating typical and atypical pulmonary carcinoids.

Authors:  Tarun Jindal; Arvind Kumar; Balasubramanian Venkitaraman; Monika Meena; Rakesh Kumar; Arun Malhotra; Roman Dutta
Journal:  Cancer Imaging       Date:  2011-06-15       Impact factor: 3.909

View more
  5 in total

Review 1.  PET/CT assessment of neuroendocrine tumors of the lung with special emphasis on bronchial carcinoids.

Authors:  Filippo Lococo; Alfredo Cesario; Massimiliano Paci; Angelina Filice; Annibale Versari; Cristian Rapicetta; Tommaso Ricchetti; Giorgio Sgarbi; Marco Alifano; Alberto Cavazza; Giorgio Treglia
Journal:  Tumour Biol       Date:  2014-05-22

2.  Theranostic implications of molecular imaging phenotype of well-differentiated pulmonary carcinoid based on 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT.

Authors:  Lamiaa Zidan; Amir Iravani; Grace Kong; Tim Akhurst; Michael Michael; Rodney J Hicks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-06-22       Impact factor: 9.236

Review 3.  PET imaging in ectopic Cushing syndrome: a systematic review.

Authors:  Prasanna Santhanam; David Taieb; Luca Giovanella; Giorgio Treglia
Journal:  Endocrine       Date:  2015-07-25       Impact factor: 3.633

4.  Alternative and New Radiopharmaceutical Agents for Lung Cancer.

Authors:  Silvi Telo; Letizia Calderoni; Sara Vichi; Federico Zagni; Paolo Castellucci; Stefano Fanti
Journal:  Curr Radiopharm       Date:  2020

5.  Is fludeoxyglucose-fluorodeoxyglucose-positron emission tomography/computed tomography ((18)F-FDG-PET/CT) really useless in staging pulmonary carcinoid tumors and in discriminating histological subtypes? Controversial points and future perspectives.

Authors:  Filippo Lococo; Alessandro Stefani; Giorgio Treglia
Journal:  Ann Thorac Med       Date:  2015 Jul-Sep       Impact factor: 2.219

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.